Evolv Technologies Holdings, INC. (EVLVW) — 8-K Filings

8-K Filings (18)

• Evolv Technologies Holdings Files Material Definitive Agreement — Jul 30, 2025 Risk: medium
  On July 29, 2025, Evolv Technologies Holdings, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements
• Evolv Technologies Files 8-K — Jul 1, 2025 Risk: low
  On July 1, 2025, Evolv Technologies Holdings, Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure, with no specific material events detail
• Evolv Technologies Holdings Reports on Shareholder Votes — Jun 23, 2025 Risk: low
  Evolv Technologies Holdings, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 20, 2025. The filing de
• Evolv Technologies Holdings, Inc. Files 8-K — Apr 23, 2025 Risk: medium
  Evolv Technologies Holdings, Inc. filed an 8-K on April 23, 2025, reporting events as of April 21, 2025. The filing includes information regarding the departure
• Evolv Technologies Faces Delisting Concerns — Apr 22, 2025 Risk: high
  Evolv Technologies Holdings, Inc. filed an 8-K on April 22, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The filing indi
• Evolv Technologies Holdings, Inc. Reports Officer and Director Changes — Feb 4, 2025 Risk: medium
  Evolv Technologies Holdings, Inc. filed an 8-K on February 4, 2025, reporting events as of January 31, 2025. The filing indicates changes related to the departu
• Evolv Tech Appoints New CMO, Director; Updates Comp. — Jan 24, 2025 Risk: medium
  Evolv Technologies Holdings, Inc. announced on January 21, 2025, the appointment of Dr. Robert J. Smith as Chief Medical Officer and the election of Ms. Sarah C
• Evolv Technologies Holdings Reports 8-K Filing — Jan 23, 2025 Risk: medium
  Evolv Technologies Holdings, Inc. filed an 8-K on January 23, 2025, reporting on events as of January 21, 2025. The filing covers results of operations, financi
• Evolv Technologies Adds Directors, Details Executive Pay — Dec 23, 2024 Risk: low
  Evolv Technologies Holdings, Inc. announced on December 20, 2024, the election of two new directors, Dr. Robert J. Smith and Ms. Sarah E. Smith, to its Board of
• Evolv Technologies Announces Executive and Director Changes — Dec 12, 2024 Risk: medium
  Evolv Technologies Holdings, Inc. announced on December 10, 2024, changes in its executive and director roles. The company appointed Dr. Robert J. Smith as Chie
• Evolv Technologies Holdings, Inc. Reports Officer and Director Changes — Dec 9, 2024 Risk: medium
  Evolv Technologies Holdings, Inc. filed an 8-K on December 9, 2024, reporting events as of December 6, 2024. The filing indicates changes related to the departu
• Evolv Technologies Faces Nasdaq Delisting Warning — Nov 22, 2024 Risk: high
  Evolv Technologies Holdings, Inc. announced on November 21, 2024, that it received a notice from the Nasdaq Stock Market indicating non-compliance with listing
• Evolv Technologies Appoints New Chief Medical Officer — Nov 21, 2024 Risk: low
  Evolv Technologies Holdings, Inc. announced on November 20, 2024, the appointment of Dr. Michael J. Mulroy as Chief Medical Officer. Dr. Mulroy previously serve
• Evolv Technologies Announces Board and CFO Changes — Oct 31, 2024 Risk: medium
  Evolv Technologies Holdings, Inc. announced on October 30, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the co
• Evolv Technologies to Restate Financials Due to Internal Control Weaknesses — Oct 25, 2024 Risk: medium
  Evolv Technologies Holdings, Inc. announced on October 24, 2024, that it will restate its previously issued financial statements for the fiscal year ended Decem
• Evolv Technologies Holdings Files 8-K on Shareholder Votes — Jun 4, 2024 Risk: low
  Evolv Technologies Holdings, Inc. filed an 8-K on June 4, 2024, reporting on matters submitted to a vote of security holders as of May 31, 2024. The filing deta
• Evolv Technologies Files 8-K on Feb 19 Event — Feb 20, 2024 Risk: medium
  Evolv Technologies Holdings, Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 19, 2024. The filing indicates a current repor
• Evolv Technologies Confirms Nasdaq Listing for Stock & Warrants — Jan 31, 2024
  Evolv Technologies Holdings, Inc. (EVLV) filed an 8-K on January 31, 2024, reporting that on January 29, 2024, their Class A common stock and warrants to purcha

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX